Idiopathic pulmonary fibrosis – Life with Disease

Go back

Idiopathic pulmonary fibrosis is a serious lung disease that changes lives in ways many people never anticipate. The scarring that develops in the lungs makes breathing progressively harder, and the journey with this condition requires courage, adaptation, and support from loved ones and healthcare teams.

Understanding What Lies Ahead: Prognosis

When someone receives a diagnosis of idiopathic pulmonary fibrosis, one of the first questions that comes to mind is often about the future. It’s important to approach this topic with both honesty and compassion, because the outlook for IPF varies considerably from person to person.[1]

The disease is described as progressive, which means it gets worse over time, but the speed at which this happens differs greatly among individuals. Some people remain relatively stable for years, experiencing only gradual changes in their breathing capacity. Others may find that their condition deteriorates more quickly, with symptoms becoming more limiting in a shorter timeframe.[3]

Research suggests that the average life expectancy following diagnosis is approximately three to five years, though this statistic was established before newer treatments became widely available.[7][8] It’s crucial to understand that these are averages, not predictions for any individual. Many factors influence how long someone with IPF will live, including their age at diagnosis, overall health, how well they respond to treatment, and whether they develop complications.[4]

Some people respond well to available medications and remain relatively free of debilitating symptoms for many years. The introduction of antifibrotic drugs has begun to shift the landscape, offering hope that survival times may improve as these treatments become more established.[4][13]

⚠️ Important
The progression of IPF is highly unpredictable and cannot be determined at the time of diagnosis. Regular monitoring by your healthcare team is essential to understand how your specific case is developing and to adjust your care plan accordingly.

How the Disease Develops Without Treatment

If idiopathic pulmonary fibrosis is left untreated, the natural course of the disease involves continued scarring and thickening of lung tissue. This process is called fibrosis, and it fundamentally changes the structure of the lungs.[1]

The lungs contain millions of tiny air sacs called alveoli, where oxygen from the air we breathe passes into the bloodstream. In IPF, the tissue surrounding these air sacs becomes damaged and increasingly scarred. As more scar tissue forms, the lungs lose their natural elasticity and become stiff. This stiffness makes it progressively harder to expand the lungs fully and take deep breaths.[1][6]

Over time, the scarred tissue interferes with the transfer of oxygen from the lungs into the blood. Without treatment, the amount of oxygen reaching the body’s organs and tissues gradually decreases. This leads to worsening shortness of breath, first during physical activity and eventually even at rest. Simple tasks that once required no thought, like walking to the mailbox or climbing a few stairs, become exhausting challenges.[3]

The relentless progression of scarring means that lung function continues to decline. The body struggles to get enough oxygen, and symptoms such as persistent dry cough, extreme tiredness, and unintended weight loss become more pronounced. Eventually, without intervention, the lungs cannot deliver sufficient oxygen to sustain the body’s vital functions, leading to respiratory failure, a life-threatening condition where the lungs can no longer support breathing without help.[1][6]

Complications That May Arise

Living with idiopathic pulmonary fibrosis means being aware of potential complications that can develop as the disease progresses. These complications can significantly affect quality of life and overall health.[1]

One of the most serious complications is pulmonary hypertension, which is high blood pressure in the arteries that carry blood from the heart to the lungs. As the lungs become more scarred and stiff, the heart has to work harder to pump blood through them. This increased strain can lead to thickening and stiffening of the blood vessel walls in the lungs, raising the pressure within them. Over time, this added burden on the heart can lead to heart failure, where the heart becomes too weak to pump blood effectively.[1][6][7]

Another complication is low oxygen levels in the blood, a condition called hypoxemia, and in the body’s tissues, known as hypoxia. When the lungs cannot deliver enough oxygen to the bloodstream, the brain and other organs don’t receive what they need to function properly. This can cause confusion, dizziness, and damage to organs over time.[6]

People with IPF are also at higher risk of developing lung infections, including pneumonia. The damaged lung tissue provides a less effective defense against bacteria and viruses. These infections can be more severe in people with already compromised lung function.[4][8]

A particularly frightening complication is what doctors call an acute exacerbation. This is a sudden, severe worsening of symptoms that happens over a period of days or weeks. During an exacerbation, breathing difficulties intensify rapidly, and the person may require hospitalization and intensive support. The exact cause of these episodes is not always clear, though sometimes they are triggered by infections or other stressors. Exacerbations are serious and can be life-threatening.[1][14]

Other complications can include a collapsed lung, blood clots in the lungs, and an increased risk of lung cancer. These additional problems underscore the importance of regular medical monitoring and prompt attention to any new or worsening symptoms.[6][8]

The Impact on Daily Life

Living with idiopathic pulmonary fibrosis brings changes that touch every aspect of daily life. The physical limitations are often the most obvious, but the emotional and social effects can be equally profound.[21]

Physically, the progressive shortness of breath means that activities once taken for granted become difficult or impossible. Getting dressed, taking a shower, cooking a meal, or walking from room to room can leave someone breathless and exhausted. Many people find they need to slow down, take frequent breaks, or ask for help with tasks they used to manage independently. This loss of physical capability can be deeply frustrating.[3][9]

The persistent dry cough that accompanies IPF can be disruptive and socially embarrassing. It may interrupt conversations, disturb sleep, and make it uncomfortable to be in public places. Some people become self-conscious about coughing around others and may avoid social situations as a result.[7][20]

Work life is often significantly affected. Jobs that require physical exertion become impossible, and even desk jobs can be challenging if they involve long commutes or environments with poor air quality. Many people with IPF find they need to reduce their work hours, change roles, or stop working altogether, which can bring financial strain and a sense of lost identity.[17]

Hobbies and recreational activities that once brought joy may need to be modified or abandoned. Gardening, hiking, dancing, or playing with grandchildren might no longer be possible in the same way. Finding new, less physically demanding activities can help, but the loss of beloved pastimes is a genuine grief.[18]

Emotionally, living with IPF is challenging. Feelings of anger, fear, sadness, and frustration are common and completely normal. Many people experience anxiety about the future, depression over losses already experienced, and stress from managing a complex medical condition. The unpredictability of the disease adds to the emotional burden, as it’s difficult to make plans when you don’t know how you’ll feel from one day to the next.[21]

Relationships can also be affected. Family members and friends may struggle to understand what you’re going through, or they may not know how to help. Some people with IPF feel isolated or worry about being a burden. Open communication with loved ones about needs and feelings can help maintain strong connections during this difficult time.[17]

Many people benefit from learning coping strategies and connecting with others who have IPF. Support groups, whether in person or online, provide a space to share experiences, exchange practical tips, and feel less alone. Pulmonary rehabilitation programs teach breathing techniques, energy conservation methods, and exercise routines adapted to lung limitations, which can improve quality of life and confidence in managing daily activities.[10][22]

⚠️ Important
Adjusting to life with IPF is a process that takes time. Allow yourself to feel all the emotions that come up, even when they’re uncomfortable. Seeking support from healthcare providers, mental health professionals, and patient communities can make a significant difference in maintaining your well-being.

Supporting Family Members Through Clinical Trials

For families of someone living with idiopathic pulmonary fibrosis, understanding clinical trials and how to support participation in research can be an important part of the journey. Clinical trials are research studies that test new treatments or approaches to managing disease. They are essential for advancing medical knowledge and developing better therapies for IPF.[1]

Family members should know that participation in clinical trials is always voluntary. No one should feel pressured to enroll, and patients can withdraw from a trial at any time without affecting their regular medical care. However, for some people with IPF, participating in a trial offers access to promising new treatments before they become widely available. It also provides an opportunity to contribute to research that may help future patients.[19]

When considering a clinical trial, it’s important for both patients and families to understand what is involved. Trials have specific eligibility criteria, meaning not everyone with IPF will qualify for every study. The research team will explain the purpose of the trial, what procedures or treatments are involved, how long participation will last, and what potential risks and benefits exist. This information is provided in a document called an informed consent form, which should be read carefully and discussed thoroughly.[19]

Families can help by attending medical appointments and asking questions alongside the patient. Some important questions to consider include: What is the goal of this trial? What treatments or procedures are involved? How often will visits be required? What are the possible side effects? Will participation involve extra costs? What happens if the treatment doesn’t work or causes problems?[17]

Supporting someone through trial participation may involve practical assistance, such as providing transportation to appointments, helping keep track of medications or symptom logs, and offering emotional encouragement. Trials can be demanding, with frequent visits and monitoring, so having a supportive family member can make participation more manageable.[17]

Families should also be aware that clinical trials are carefully designed to protect participants. They are overseen by ethics committees and regulatory bodies that ensure patient safety is the top priority. If any concerning side effects or problems arise, they should be reported to the research team immediately.[19]

Finding clinical trials for IPF can be done through several resources. Healthcare providers can recommend trials that might be appropriate. Online databases, such as those maintained by patient advocacy organizations and government health agencies, list ongoing studies and provide contact information for enrollment. The Pulmonary Fibrosis Foundation and similar organizations often have resources and support networks to help patients and families navigate the clinical trial process.[2][19]

Ultimately, the decision to participate in a clinical trial is deeply personal and should be made by the patient in consultation with their healthcare team and loved ones. For families, the most important role is to provide information, support, and respect for whatever decision is made.[17]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Pirfenidone (Esbriet®) – An antifibrotic and anti-inflammatory drug that slows the scarring process in the lungs and has been shown to slow progression in mild-to-moderate idiopathic pulmonary fibrosis. It is taken orally three times a day.
  • Nintedanib (OFEV®) – A tyrosine kinase inhibitor with antifibrotic properties that slows the decline in lung function in idiopathic pulmonary fibrosis, scleroderma-associated interstitial lung disease, and progressive fibrosing interstitial lung diseases. It is taken orally twice a day.

Ongoing Clinical Trials on Idiopathic pulmonary fibrosis

  • Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia France Ireland The Netherlands Spain
  • Study of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment

    Recruiting

    Investigated diseases:
    Belgium Germany Italy Spain
  • Study of inhaled LTI-03 for safety and effectiveness in patients with Idiopathic Pulmonary Fibrosis who may be receiving standard antifibrotic therapy

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • Long-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis

    Recruiting

    1 1
    Investigated drugs:
    Czechia France Germany Italy The Netherlands Poland +1
  • Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on the Effects of Methylprednisolone and Prednisone for Treating Acute Flare-Ups in Idiopathic Pulmonary Fibrosis Patients

    Recruiting

    1 1
    Investigated diseases:
    France
  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Recruiting

    1 1 1
    Investigated diseases:
    Austria Belgium Croatia Czechia Denmark Estonia +14
  • A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

    Not yet recruiting

    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Italy +4
  • Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

    Not yet recruiting

    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain
  • A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

    Not yet recruiting

    Investigated diseases:
    Bulgaria France Germany Greece Hungary Italy +5

References

https://www.nhlbi.nih.gov/health/idiopathic-pulmonary-fibrosis

https://www.pulmonaryfibrosis.org/understanding-pff/types-of-pulmonary-fibrosis/idiopathic-pulmonary-fibrosis

https://www.mayoclinic.org/diseases-conditions/pulmonary-fibrosis/symptoms-causes/syc-20353690

https://www.nhs.uk/conditions/idiopathic-pulmonary-fibrosis/

https://www.lung.org/lung-health-diseases/lung-disease-lookup/idiopathic-pulmonary-fibrosis

https://my.clevelandclinic.org/health/diseases/10959-pulmonary-fibrosis

https://www.actionpf.org/information-support/idiopathic-pulmonary-fibrosis

https://en.wikipedia.org/wiki/Idiopathic_pulmonary_fibrosis

https://www.upmc.com/services/pulmonology/conditions/ipf

https://www.nhs.uk/conditions/idiopathic-pulmonary-fibrosis/treatment/

https://www.mayoclinic.org/diseases-conditions/pulmonary-fibrosis/diagnosis-treatment/drc-20353695

https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/patients/how-is-pulmonary-fibrosis-treated/medications

https://pmc.ncbi.nlm.nih.gov/articles/PMC9060042/

https://emedicine.medscape.com/article/301226-treatment

https://www.pulmonaryfibrosis.org/understanding-pff/treatment-options/medications

https://news.vumc.org/2025/01/08/study-suggests-a-new-way-to-treat-incurable-lung-disease/

https://www.pulmonaryfibrosis.org/patients-caregivers/education-resources/maintain-your-health

https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/patients/living-well-with-pulmonary-fibrosis/living-with-pulmonary

https://www.nhlbi.nih.gov/health/idiopathic-pulmonary-fibrosis/living-with

https://pfwarriors.com/5-secrets-from-patients-living-with-pulmonary-fibrosis/

https://www.nationaljewish.org/education/health-information/living-with-idiopathic-pulmonary-fibrosis

https://www.nhs.uk/conditions/idiopathic-pulmonary-fibrosis/treatment/

FAQ

Can idiopathic pulmonary fibrosis be cured?

No, there is currently no cure for idiopathic pulmonary fibrosis. However, certain treatments, including medications like pirfenidone and nintedanib, may slow the progression of the disease and help lungs work better, which can extend lifespan and improve quality of life for people who have IPF.

What causes the scarring in idiopathic pulmonary fibrosis?

The exact cause is unknown, which is why it is called “idiopathic.” However, the disease has been linked to smoking, certain environmental exposures such as metal or wood dust, viral infections, acid reflux, and a family history of IPF. It likely results from a combination of genetic and environmental factors that lead to damage of the cells lining the air sacs in the lungs.

How is idiopathic pulmonary fibrosis diagnosed?

Diagnosis typically involves a combination of tests. Your doctor will review your medical history, perform a physical exam listening to your lungs, and order imaging tests like chest X-rays and high-resolution CT scans. Breathing tests to measure lung function, blood tests, and sometimes a lung biopsy may also be needed to confirm the diagnosis and rule out other conditions.

Will I need to use supplemental oxygen if I have IPF?

Many people with IPF eventually need supplemental oxygen as the disease progresses and oxygen levels in the blood fall. Oxygen therapy can help reduce shortness of breath and allow you to be more active. Some people only need oxygen during physical activity, while others may need it continuously. Portable oxygen devices are available for use outside the home.

Is lung transplantation an option for idiopathic pulmonary fibrosis?

For some people with IPF, lung transplantation may be considered. This is a major procedure and the decision depends on factors such as how severe your condition is, how quickly it is progressing, your age and overall health, and whether a donor lung is available. Lung transplantation is the only treatment shown to significantly increase life expectancy in people with IPF.

🎯 Key takeaways

  • Idiopathic pulmonary fibrosis causes progressive scarring of the lungs, making it increasingly difficult to breathe, though the speed of progression varies widely among individuals.
  • The disease typically affects people in their 60s and 70s and is more common in men than women.
  • Two antifibrotic medications, pirfenidone and nintedanib, can slow the scarring process and help preserve lung function in many people with IPF.
  • Sudden, severe worsening of symptoms called acute exacerbations can occur and are serious, often requiring hospitalization.
  • Complications of IPF include pulmonary hypertension, heart failure, low oxygen levels, and increased risk of lung infections.
  • Daily life with IPF changes significantly, affecting physical abilities, work, hobbies, and emotional well-being, but coping strategies and support can help.
  • Pulmonary rehabilitation programs teach breathing techniques and energy conservation that can improve quality of life.
  • Lung transplantation is the only treatment shown to extend life expectancy, though it is not suitable for everyone.